The University of Oxford soon kicks “the PRINCIPLE Trial” into a higher gear now, in what they consider a pathbreaking “high-quality […]
The Drugs Controller General of India (DCGI) issued emergency authorization for two vaccines, including ‘COVISHIELD’, produced by the Serum Institute […]
A Chinese collaborative is working on a similar vaccine to the one developed by the University of Oxford that is […]
The AstraZeneca COVID-19 vaccine trial, investigating the safety and efficacy of the “Oxford” vaccine now known as AZD1222, has come […]
TrialSite recently reported that the independent data monitoring committee recommended to continue the Montreal Heart Institute study investigating the use of […]
Recently, experts from Oxford University and the World Health Organization (WHO) shared that additional data would be required about AZD1222, […]
The University of Oxford will take part in a new pilot scheme to assess the use of Lateral Flow Tests […]
TrialSite has chronicled the onset of the AstraZeneca Phase 3 trial, investigating what was purportedly one of the frontrunning COVID-19 […]
Shares of AstraZeneca’s stock declined as a volunteer participating in the Phase 3 clinical trial in Brazil died, reports Brazil’s […]
Oxford Biomedica notes Axovant’s positive six-month follow-up from second cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD Oxford, UK […]